tiprankstipranks
Par Drugs and Chemicals Limited (IN:PAR)
:PAR
India Market
Want to see IN:PAR full AI Analyst Report?

Par Drugs and Chemicals Limited (PAR) Ratios

2 Followers

Par Drugs and Chemicals Limited Ratios

IN:PAR's free cash flow for Q2 2026 was ₹0.63. For the 2026 fiscal year, IN:PAR's free cash flow was decreased by ₹ and operating cash flow was ₹0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.57 3.31 4.79 3.53 2.93
Quick Ratio
3.26 2.94 4.44 3.11 2.56
Cash Ratio
1.93 1.66 2.95 1.59 1.09
Solvency Ratio
0.83 0.83 1.12 0.83 0.66
Operating Cash Flow Ratio
0.46 0.98 1.63 0.96 0.51
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
₹ 413.42M₹ 344.46M₹ 436.44M₹ 318.07M₹ 247.51M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.20 1.21 1.19 1.25 1.31
Debt Service Coverage Ratio
173.34 181.93 167.48 110.36 28.34
Interest Coverage Ratio
160.42 195.18 515.02 109.29 27.86
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.07 0.07 0.09 0.11 0.37
Net Debt to EBITDA
-1.66 -1.41 -1.60 -1.21 -0.99
Profitability Margins
Gross Profit Margin
56.22%62.24%63.77%30.17%32.62%
EBIT Margin
15.74%15.70%20.41%16.00%17.53%
EBITDA Margin
19.20%19.31%24.00%19.40%21.93%
Operating Profit Margin
13.56%15.87%57.67%15.31%16.96%
Pretax Profit Margin
17.63%17.75%20.41%15.86%17.03%
Net Profit Margin
13.07%13.23%15.16%11.92%12.35%
Continuous Operations Profit Margin
13.07%13.23%15.16%11.92%12.35%
Net Income Per EBT
74.17%74.53%74.30%75.16%72.53%
EBT Per EBIT
130.00%111.85%35.38%103.59%100.38%
Return on Assets (ROA)
10.90%11.19%14.27%12.75%11.71%
Return on Equity (ROE)
13.87%13.50%16.93%15.91%15.39%
Return on Capital Employed (ROCE)
13.11%15.58%61.86%19.44%19.83%
Return on Invested Capital (ROIC)
9.72%11.62%45.96%14.61%14.38%
Return on Tangible Assets
10.90%11.19%14.27%12.74%11.69%
Earnings Yield
12.41%12.53%5.32%6.58%4.69%
Efficiency Ratios
Receivables Turnover
6.00 6.01 6.93 5.58 4.01
Payables Turnover
5.16 3.50 6.47 8.21 4.68
Inventory Turnover
8.82 6.24 7.84 11.13 9.07
Fixed Asset Turnover
2.82 2.59 2.31 2.46 2.17
Asset Turnover
0.83 0.85 0.94 1.07 0.95
Working Capital Turnover Ratio
4.74 2.36 2.31 2.96 2.77
Cash Conversion Cycle
31.45 14.97 42.85 53.75 53.15
Days of Sales Outstanding
60.79 60.78 52.70 65.42 90.94
Days of Inventory Outstanding
41.37 58.45 46.57 32.80 40.25
Days of Payables Outstanding
70.71 104.26 56.42 44.48 78.04
Operating Cycle
102.16 119.22 99.27 98.23 131.19
Cash Flow Ratios
Operating Cash Flow Per Share
6.58 13.14 16.45 10.87 6.19
Free Cash Flow Per Share
5.99 12.14 11.51 4.67 3.59
CapEx Per Share
0.59 1.00 4.94 6.20 2.60
Free Cash Flow to Operating Cash Flow
0.91 0.92 0.70 0.43 0.58
Dividend Paid and CapEx Coverage Ratio
11.23 13.17 3.33 1.75 1.61
Capital Expenditure Coverage Ratio
11.23 13.17 3.33 1.75 2.38
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.08 0.16 0.21 0.14 0.10
Free Cash Flow Yield
6.58%14.01%5.20%3.33%2.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.06 7.98 18.79 15.20 21.34
Price-to-Sales (P/S) Ratio
1.05 1.06 2.85 1.81 2.63
Price-to-Book (P/B) Ratio
1.05 1.08 3.18 2.42 3.28
Price-to-Free Cash Flow (P/FCF) Ratio
15.19 7.14 19.23 29.99 44.54
Price-to-Operating Cash Flow Ratio
13.84 6.60 13.45 12.88 25.81
Price-to-Earnings Growth (PEG) Ratio
-0.81 -1.02 0.67 0.66 -1.03
Price-to-Fair Value
1.05 1.08 3.18 2.42 3.28
Enterprise Value Multiple
3.83 4.05 10.27 8.13 11.02
Enterprise Value
781.90M 790.39M 2.36B 1.50B 1.80B
EV to EBITDA
3.83 4.05 10.27 8.13 11.02
EV to Sales
0.74 0.78 2.47 1.58 2.42
EV to Free Cash Flow
10.60 5.29 16.64 26.12 40.87
EV to Operating Cash Flow
9.66 4.89 11.64 11.21 23.68
Tangible Book Value Per Share
86.50 80.47 69.56 57.90 48.66
Shareholders’ Equity Per Share
86.50 80.47 69.56 57.90 48.66
Tax and Other Ratios
Effective Tax Rate
0.26 0.25 0.26 0.25 0.27
Revenue Per Share
86.45 82.09 77.69 77.28 60.64
Net Income Per Share
11.30 10.86 11.78 9.21 7.49
Tax Burden
0.74 0.75 0.74 0.75 0.73
Interest Burden
1.12 1.13 1.00 0.99 0.97
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.11 0.06 0.02 0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.62 1.21 1.40 0.89 0.60
Currency in INR